somatuline autogel 60 mg injektioneste, liuos, esitäytetty ruisku
abacus medicine a/s - lanreotide acetate - injektioneste, liuos, esitäytetty ruisku - 60 mg - lanreotidi
somatuline autogel 90 mg injektioneste, liuos, esitäytetty ruisku
abacus medicine a/s - lanreotide acetate - injektioneste, liuos, esitäytetty ruisku - 90 mg - lanreotidi
rectogesic 4 mg/g rektaalivoide
abacus medicine a/s - glycerol trinitrate - rektaalivoide - 4 mg/g - glyseryylitrinitraatti
sandimmun neoral 100 mg/ml oraaliliuos
abacus medicine a/s - ciclosporin - oraaliliuos - 100 mg/ml - siklosporiini
feiba 50 u/ml infuusiokuiva-aine ja liuotin, liuosta varten
abacus medicine a/s - tekijä viii: n estäjä ohittaen toimintaa - infuusiokuiva-aine ja liuotin, liuosta varten - 50 u/ml - hyytymistekijä viii:n vasta-aineen ohittava aine
yasmin 0.03 mg / 3 mg tabletti, kalvopäällysteinen
abacus medicine a/s - ethinylestradiol, drospirenone - tabletti, kalvopäällysteinen - 0.03 mg / 3 mg - drospirenoni ja etinyyliestradioli
propecia 1 mg tabletti, kalvopäällysteinen
abacus medicine a/s - finasteride - tabletti, kalvopäällysteinen - 1 mg - finasteridi
fucicort 20 mg/g + 1 mg/g emulsiovoide
abacus medicine a/s - betamethasone valerate, fusidic acid - emulsiovoide - 20 mg/g + 1 mg/g - beetametasoni ja antibiootit
mercilon tabletti
abacus medicine a/s - desogestrel, ethinylestradiol - tabletti - desogestreeli ja etinyyliestradioli
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiset aineet - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.